We are live on ! Find out more
CDLX icon

Cardlytics

142 hedge funds and large institutions have $795M invested in Cardlytics in 2020 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 48 increasing their positions, 53 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more call options, than puts

Call options by funds: $4.5M | Put options by funds: $3.5M

0.44% less ownership

Funds ownership: 8.95%8.51% (-0.44%)

9% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 53

9% less funds holding

Funds holding: 156142 (-14)

26% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 47

27% less funds holding in top 10

Funds holding in top 10: 118 (-3)

45% less capital invested

Capital invested by funds: $1.45B → $795M (-$652M)

Holders
142
Holders Change
-14
Holders Change %
-8.97%
% of All Funds
3.13%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.18%
New
35
Increased
48
Reduced
53
Closed
47
Calls
$4.5M
Puts
$3.5M
Net Calls
+$1M
Net Calls Change
+$2.34M

CDLX Hedge Fund Activity: Q1 2020 in Review

142 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2020, worth a combined $795M — down 45% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of CDLX and 35 opened new positions — a net loss of 12 holders — while 53 trimmed existing stakes and 48 added.

The largest buyer was CAS Investment Partners, adding an estimated $80M. The largest seller was Fidelity Investments, cutting an estimated $168M.

  • 142 institutional investors held Cardlytics (CDLX) as of Q1 2020, down from 156 in Q4 2019.
  • Funds reported $795M of Cardlytics stock for Q1 2020, down 45% quarter-over-quarter.
  • 35 funds opened new Cardlytics positions in Q1 2020 and 47 closed out, a net change of -12 holders.
  • The largest Cardlytics buyer in Q1 2020 was CAS Investment Partners, an estimated $80M added.
  • The largest Cardlytics seller in Q1 2020 was Fidelity Investments, an estimated $168M sold.

Based on aggregated 13F filings for Q1 2020.